WELCOME TO FIERCE LIFE SCIENCES WEEKLY DIGEST Your roundup of the biggest and most popular stories from each of our publications. | |
|
Featured Story | By Annalee Armstrong “It took a village to make me.” These words spoken by WeiQing Zhou, who is the cofounder of two biotechs, could apply to almost any of the women on the 2021 Fiercest Women in Life Sciences list. read more |
| |
|---|
|
Top Stories Of The Week By Ben Adams Although AstraZeneca and Moderna are archrivals in the COVID-19 vaccine space, the two have an interesting mRNA pact that has been operating largely under the radar. read more By Annalee Armstrong Glen de Vries, co-founder of the life sciences software provider Medidata, died in a plane crash last week, less than a month after flying to space with William Shatner aboard a Blue Origin rocket. read more By Kevin Dunleavy Continuing a trend, especially among the largest firms in the pharmaceutical industry, Johnson & Johnson will form a new company to handle its consumer health business. The launch of the new publicly traded company is expected in 18 to 24 months. read more By Eric Sagonowsky After a period of "stagnant" growth at BioMarin—as characterized by one analyst team—the drugmaker could be on the brink of its next big launch. The company's dwarfism drug Voxzogo already has its European approval in hand, and it's due for an FDA decision later this week. read more By Andrea Park Months after Philips received the FDA’s go-ahead to begin repairing and replacing the ventilators affected by the Class I recall the company initiated in mid-June, the regulator identified a potential safety risk with a replacement component. read more By Kevin Dunleavy Three months after earning an approval to treat chronic heart failure with Jardiance, Eli Lilly and Boehringer Ingelheim have posted data that show the drug’s effectiveness against another type of heart failure. read more By Nick Paul Taylor Al Sandrock is retiring as head of R&D at Biogen. After 23 years at the company, the scientist will clear his desk by the end of the year, leaving behind a legacy of big R&D successes that are currently overshadowed by the controversial development and approval of Aduhelm. read more By Kyle LaHucik Vanderbilt researchers used CRISPR gene editing to pinpoint a metabolic enzyme that they believe could be blocked to treat MS and other inflammatory diseases. The target had been investigated in cancer before but never made it into clinical trials. read more By Angus Liu European regulators don’t plan to go down the same controversial path as their U.S. counterparts did in approving Biogen’s Eisai-partnered Alzheimer’s disease therapy, Aduhelm. And for Biogen, as one analyst sees it, 40% of potential revenue on the drug is going down the drain. read more By Angus Liu The Chinese pharma manufacturer that was the first domino to fall in the high-profile scrutiny over possible cancer-causing impurities in heart drugs has overcome an FDA warning letter three years after the regulatory sanction. read more |
| Webinar: A Systems Model of Gene Therapy for Sickle Cell Disease Tuesday, November 30 | 2pm ET / 11am PT Stem cell gene therapy is an emerging experimental therapy for SCD with the potential for lifelong cure but it is an expensive multi-step treatment regimen. This webinar is ideal for scientists and decision makers in drug R&D who want to leverage systems pharmacology for drug discovery and development. Register Now. |
Resources Sponsored by: Thermo Scientific Production Chemicals and Services Learn how a CDMO partnered with Thermo Fisher Scientific to manage high-volume process liquid and buffer preparation scale-up. Download the free case study from Thermo Fisher Scientific Sponsored by: Medable, Inc. Find out how to improve clinical protocol adherence, and thus patient outcomes, by 15%+ with Medable’s latest White Paper. Sponsored by: IQVIA Learn how to elevate your omnichannel marketing strategy with Next Best - a combination of data and analytics, deployed to facilitate decision making. Sponsored by: Catalent Biologics Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. Sponsored by: Catalent Biologics Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Sponsored by: Blue Matter Consulting Paper describing how the chronic insomnia market offers big lessons for any biopharma company thinking about getting into digital therapeutics in any therapeutic area. Sponsored by: TransPerfect Life Sciences Every detail is important when selecting a new eCOA solution; learn more about the current eCOA landscape, best practices, and crucial considerations for successful eCOA solution deployment in this white paper. Sponsored by: Informa Pharma Intelligence and Oracle Health Sciences New market research provides valuable insight into the impact of adaptations made in clinical trials during the pandemic. Sponsored by: Thermo Fisher Scientific Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific Sponsored by: Box Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization. Sponsored By: Remarque Systems Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. | 